Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
Open Access
- 2 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
Abstract
Bromodomain (BRD) proteins exhibit a variety of activities, such as histone modification, transcription factor recruitment, chromatin remodeling, and mediator or enhancer complex assembly, that affect transcription initiation and elongation. These proteins also participate in epigenetic regulation. Although specific epigenetic regulation plays an important role in the occurrence and development of cancer, the characteristics of the BRD family in renal clear cell carcinoma (KIRC) have not been determined. In this study, we investigated the expression of BRD family genes in KIRC at the transcriptome level and examined the relationship of the expression of these genes with patient overall survival. mRNA levels of tumor tissues and adjacent tissues were extracted from The Cancer Genome Atlas (TCGA) database. Seven BRD genes (KAT2A, KAT2B, SP140, BRD9, BRPF3, SMARCA2, and EP300) were searched by using LASSO Cox regression and the model with prognostic risk integration. The patients were divided into two groups: high risk and low risk. The combined analysis of these seven BRD genes showed a significant association with the high-risk groups and lower overall survival (OS). This analysis demonstrated that total survival could be predicted well in the low-risk group according to the time-dependent receiver operating characteristic (ROC) curve. The prognosis was determined to be consistent with that obtained using an independent dataset from TCGA. The relevant biological functions were identified using Gene Set Enrichment Analysis (GSEA). In summary, this study provides an optimized survival prediction model and promising data resources for further research investigating the role of the expression of BRD genes in KIRC.Funding Information
- Natural Science Foundation of Zhejiang Province
This publication has 45 references indexed in Scilit:
- Bromodomains as therapeutic targetsExpert Reviews in Molecular Medicine, 2011
- High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinomaJournal of Translational Medicine, 2011
- The p300/CBP - associated factor is frequently down-regulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcomeCancer Biology & Therapy, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinomaOncogene, 2009
- Mutations truncating the EP300 acetylase in human cancersNature Genetics, 2000
- Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex.Genes & Development, 1997
- Tumors in Rubinstein‐Taybi syndromeAmerican Journal of Medical Genetics, 1995
- Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumorsUrology, 1994
- brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activatorCell, 1992